HealthStream, Inc. (NASDAQ:HSTM) Receives $25.00 Average Price Target from Analysts

Shares of HealthStream, Inc. (NASDAQ:HSTMGet Free Report) have been given a consensus recommendation of “Hold” by the five ratings firms that are presently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $25.00.

HSTM has been the topic of a number of research analyst reports. Wall Street Zen lowered HealthStream from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of HealthStream in a report on Wednesday, October 8th. Canaccord Genuity Group set a $25.00 target price on HealthStream in a research note on Thursday, January 8th. Finally, Citigroup restated a “market perform” rating on shares of HealthStream in a report on Tuesday, January 6th.

Read Our Latest Stock Analysis on HSTM

Insiders Place Their Bets

In related news, EVP Kevin P. O’hara sold 2,000 shares of HealthStream stock in a transaction on Monday, December 8th. The stock was sold at an average price of $24.26, for a total value of $48,520.00. Following the completion of the transaction, the executive vice president directly owned 16,373 shares in the company, valued at approximately $397,208.98. This trade represents a 10.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Tate Deborah Taylor sold 1,580 shares of the company’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $25.46, for a total value of $40,226.80. Following the sale, the director owned 23,127 shares in the company, valued at approximately $588,813.42. This trade represents a 6.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 5,680 shares of company stock worth $139,336 over the last 90 days. Corporate insiders own 20.60% of the company’s stock.

Hedge Funds Weigh In On HealthStream

Several large investors have recently bought and sold shares of the business. Geode Capital Management LLC increased its holdings in shares of HealthStream by 5.3% in the 2nd quarter. Geode Capital Management LLC now owns 766,193 shares of the technology company’s stock valued at $21,202,000 after acquiring an additional 38,868 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in HealthStream during the third quarter worth approximately $1,264,000. Acadian Asset Management LLC boosted its holdings in HealthStream by 5.1% in the second quarter. Acadian Asset Management LLC now owns 762,343 shares of the technology company’s stock valued at $21,077,000 after purchasing an additional 37,004 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its stake in HealthStream by 162.1% in the second quarter. Robeco Institutional Asset Management B.V. now owns 380,604 shares of the technology company’s stock valued at $10,531,000 after purchasing an additional 235,382 shares during the last quarter. Finally, Integrated Quantitative Investments LLC raised its holdings in HealthStream by 13.4% during the second quarter. Integrated Quantitative Investments LLC now owns 41,426 shares of the technology company’s stock worth $1,146,000 after purchasing an additional 4,895 shares in the last quarter. Hedge funds and other institutional investors own 69.58% of the company’s stock.

HealthStream Price Performance

NASDAQ HSTM opened at $21.93 on Friday. The stock has a market capitalization of $650.66 million, a P/E ratio of 32.25, a PEG ratio of 2.41 and a beta of 0.44. The firm’s 50-day moving average is $23.27 and its two-hundred day moving average is $25.54. HealthStream has a 12 month low of $21.00 and a 12 month high of $34.24.

HealthStream (NASDAQ:HSTMGet Free Report) last announced its quarterly earnings results on Monday, November 3rd. The technology company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.03. HealthStream had a net margin of 6.93% and a return on equity of 5.82%. The business had revenue of $76.47 million during the quarter, compared to analysts’ expectations of $75.52 million. As a group, analysts anticipate that HealthStream will post 0.63 EPS for the current year.

HealthStream announced that its board has initiated a share buyback program on Tuesday, November 11th that allows the company to buyback $10.00 million in outstanding shares. This buyback authorization allows the technology company to purchase up to 1.3% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its shares are undervalued.

HealthStream Company Profile

(Get Free Report)

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.

Featured Articles

Analyst Recommendations for HealthStream (NASDAQ:HSTM)

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.